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ARTICLE
Amplicon sequencing provides more accurate
microbiome information in healthy children
compared to culturing
Shashank Gupta1,5, Martin S. Mortensen 1,5, Susanne Schjørring2, Urvish Trivedi1, Gisle Vestergaard1,
Jakob Stokholm 3, Hans Bisgaard 3, Karen A. Krogfelt 2,4 & Søren J. Sørensen 1
Next-Generation Sequencing (NGS) of 16S rRNA gene is now one of the most widely used
application to investigate the microbiota at any given body site in research. Since NGS is
more sensitive than traditional culture methods (TCMs), many studies have argued for them
to replace TCMs. However, are we really ready for this transition? Here we compare the
diagnostic efﬁciency of the two methods using a large number of samples (n= 1,748 fecal
and n= 1,790 hypopharyngeal), among healthy children at different time points. Here we
show that bacteria identiﬁed by NGS represented 75.70% of the unique bacterial species
cultured in each sample, while TCM only identiﬁed 23.86% of the bacterial species found by
amplicon sequencing. We discuss the pros and cons of both methods and provide per-
spective on how NGS can be implemented effectively in clinical settings.
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For decades, microbiology has relied on traditional culturemethods (TCMs) to identify bacteria involved in humanhealth or disease: typically, samples are sent to a laboratory,
and bacteria from these samples are enriched in broth and/or
agar-based media, isolated and biochemically characterized for
identiﬁcation. TCMs enable classiﬁcation of bacteria to species
and strain level, and in a clinical setting, the right choice of media
and incubation settings will enable selective growth of certain
pathogenic bacteria, the possibility to evaluate growth rate and
antimicrobial susceptibility testing. However, TCMs have many
shortcomings: a bias towards bacteria that readily proliferate
under laboratory conditions1,2, require extended incubation time
to identify organisms present3,4, only provides qualitative results,
and identiﬁes only a fraction of the diverse microbial populations
in question5. TCMs continue to be the mainstay for clinical
laboratories while NGS will potentially replace this in the future.
Molecular diagnostic techniques, such as Polymerase chain
reaction (PCR), DNA ﬁngerprinting and Next-Generation
Sequencing (NGS) have been game changers2,6. These techni-
ques have become increasingly rapid, sensitive and cost-
efﬁcient7,8. For NGS of 16S rRNA gene, DNA is ﬁrst extracted,
a speciﬁc region of 16S rRNA gene is ampliﬁed, sequenced, and
then identiﬁcation of generated sequences is based on similarity
to reference 16S rRNA gene sequences available in public data-
bases. The major advantages of 16S rRNA gene NGS are that the
method does not rely on whether or not the bacteria in a sample
is culturable, the relative abundance of all bacteria in the sample
can be determined, and it allows for parallel sequencing of
hundreds of samples simultaneously and results can be obtained
on the same day as the sample was taken9. Due to an increase in
the number of PCR and DNA sequencing facilities available, the
use of 16S rRNA gene sequencing is not limited to research
purposes, but may soon be utilized by clinical laboratories10.
However, 16S rRNA gene amplicon sequencing also has limita-
tions: the primers used for ampliﬁcation will introduce a bias as
they bind to regions that are not 100% conserved across all
bacteria, and, in most cases, bacteria can only be identiﬁed to
genus level due to high similarity between 16S rRNA gene from
closely related species, furthermore this method does not provide
information on antimicrobial susceptibility.
Efforts to compare the results from culturing and amplicon
sequencing have primarily focused on the identiﬁcation of pure
cultures. Woo et al.10 made a thorough review of the usefulness of
16S rRNA gene sequencing, where they listed diseases for which
the causative bacteria cannot be cultured. Comparison between
the methods with respect to bacterial communities has been
performed by only a few studies, looking at the bioburden in
chronic wounds5 or on a very small number of subjects11,12.
To thoroughly evaluate whether NGS is ready to replace TCMs
in diagnostics, we collected fecal samples and hypopharyngeal
aspirations from children part of the Copenhagen Prospective
Studies on Asthma in Childhood2010 (COPSAC2010) cohort13.
Initially, the microbiota of all samples were characterized using
TCMs, then followed by NGS of 16S rRNA gene; allowing us to
compare 3,538 samples that have both been cultured and
sequenced. Based on the results obtained by comparing TCMs
with amplicon sequencing, using state-of-the-art bioinformatics
and statistics, there were some discordances; TCMs identiﬁed up
to 8 bacterial species per sample, whereas NGS identiﬁed up to
140 unique species per sample. We show that bacteria identiﬁed
by NGS represented 75.70% of the unique bacterial species cul-
tured in each sample, while TCMs only identiﬁed 23.86% of the
bacterial species found by amplicon sequencing. Our data suggest
that while NGS is better at describing the microbiome in samples
from healthy children, TCMs still offers some additional infor-
mation that is needed in a clinical setting. The workﬂows and
data analysis used in this study have limitations in a clinical
setting, but with the development of a standardized and auto-
mated pipeline sequencing should be ready to replace TCMs.
Results
Sample composition by culturing. We cultivated bacteria from
1,790 hypopharyngeal samples from children aged 1 week (n=
537), 1 month (n= 626) and 3 months (n= 627) and 1748 fecal
samples from the same children aged 1 week (n= 542), 1 month
(n= 597) and 1 year (n= 609). From the totality of 3,538 sam-
ples, we isolated 9,832 pure cultures. The fecal samples contained
on average 2.7 bacterial species, most commonly we observed
Escherichia coli (56.59%), Staphylococcus epidermidis (29.46%),
and Enterococcus faecalis (23.20%) among all samples. Similarly,
the hypopharyngeal samples contained on average 2.4 bacterial
species, most commonly Staphylococcus aureus (48.28%), Sta-
phylococcus epidermidis (41.54%), and Corynebacterium spp.
(28.42%) (Table 1; full list in Supplementary Table 1).
Sample composition by next-generation sequencing. A total of
195,078,994 high-quality paired sequences were obtained from
the same 3,538 samples. The samples were rareﬁed to 1,806 reads
per sample, which represented 8,161 amplicon sequence variants
(ASVs). We classiﬁed the ASVs to species level (4% could be
identiﬁed), except for a few families, e.g. Enterobacteriaceae,
where members of different genera were not distinguishable.
Several genera had multiple ASVs associated with them, but it
was not possible to determine which unique species they repre-
sented. The majority belonged to the phyla Bacteroidetes, Fir-
micutes, Proteobacteria, Actinobacteria, Verrucomicrobia, and
Fusobacteria, which corresponded to 99.80% of all sequencing
reads (Supplementary Table 2, Supplementary Fig. 1). Bacter-
oidetes (33.27%) and Firmicutes (26.59%) accounted for the
major phyla in fecal samples, whereas it was Firmicutes (61.9%)
and Proteobacteria (29.78%) in hypopharyngeal samples (Sup-
plementary Table 2).
The dominant families, average abundance >10%, in fecal
samples were Bacteroidaceae (29.11%), Enterobacteriaceae
(23.86%) and Biﬁdobacteriaceae (15.29%), whereas, Streptococca-
ceae (25.90%), Staphylococcaceae (26.39%) and Moraxellaceae
(15.85%) dominated hypopharyngeal samples (complete list in
Supplementary Table 3).
Table 1 The ﬁve bacteria species most identiﬁed by culturing from each sample type. Percentages are the percent of samples
they have been found in
Top Five Hypopharyngeal Fecal
1 Staphylococcus aureus 48.28% Escherichia coli 56.59%
2 Staphylococcus epidermidis 41.54% Staphylococcus epidermidis 29.46%
3 Corynebacterium spp 28.42% Enterococcus faecalis 23.20%
4 Moraxella catarrhalis 20.59% Klebsiella pneumoniae 14.99%
5 Streptococcus mitis/oralis 20.06% Staphylococcus aureus 12.71%
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Direct comparison of sample composition. To establish how
well the culturing and NGS data correlated, we calculated what
proportion of the sequencing reads, within each sample, which
represented bacteria cultured from that sample. The proportion
of sequencing reads matched to cultured bacteria were highest at
phylum level and decreased as we moved towards species level.
Furthermore, within each taxonomic level, the proportion of
matched sequencing reads were highest at 1 week and decreased
over time. Moreover, there were large differences between the
sample types; bacteria cultured from fecal samples were less
abundant (mean= 21.38%) than hypopharyngeal samples
(mean= 49.65%) (Fig. 1).
Comparison using closed reference taxonomical assignment.
To improve the resolution of the amplicon sequencing data and
allow for comparison at species level we performed closed-
reference OTU picking at 100% identity for all ASVs. We com-
piled a reference database of type strains, from the Ribosomal
Database Project (RDP) database, for the species identiﬁed by
culturing. Isolates not identiﬁed to species level were disregarded.
We identiﬁed 167 unique cultured bacteria, 22 were only iden-
tiﬁed to genus level (Supplementary Table 4). In addition, we
pooled the bacteria that had identical V4 sequences, giving us 106
unique bacterial species and groups to compare (Supplementary
Table 4). Among these 106 unique bacterial species, 40 genera
were found in total, out of which the 5 most abundant genera
were Staphylococcus, Escherichia/Shigella, Enterococcus, Morax-
ella, and Streptococcus (Supplementary Table 5).
There were large differences in the sensitivity of the two
methods, TCMs identiﬁed no more than 8 bacterial species per
sample, with average 2.3 at 1 week, 2.19 at 1 month, and 2.22 at 1
year in fecal sample and 2.41 at 1 week, 2.42 at 1 month, and 2.42
at 3 months in hypopharyngeal samples. In comparison, NGS
identiﬁed up to 140 unique species per sample, averaging 22.55 at
1 week, 21.94 at 1 month, and 52.22 at 1 year in fecal samples and
16.12 at 1 week, 20.12 at 1 month, and 25.18 at 3 months in
hypopharyngeal samples (Table 2).
We then evaluated how many of the 106 identiﬁed unique
species from the TCMs had a matching NGS sequence.
Hypopharyngeal samples had the highest proportion of matching
sequences (76.63%), while a low percentage of the fecal samples
matched sequences in our reference database (27.63%) (Supple-
mentary Fig. 2). Moreover, as the infant gets older, the mean
proportion of matching sequences decreased. We observed that
1 week fecal samples had the highest percentage (40.36%) matched
to reference database compare to 1 month (35.86%) and 1 year
(8.21%). Similarly, among hypopharyngeal samples, 1 week had
the highest percentage (80.67%) matched to reference database
compare to 1 month (76.03%), and 3 months (73.71%). This could
resemble the increasing abundance of anaerobic bacteria in the
samples with time, which is especially found in the fecal samples.
When considering a presence/absence scenario for the
106 species, 75.7% of the times a bacterium was found and
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Fig. 1 Boxplot showing the mean relative abundance of bacteria, classiﬁed using ASVs, matching bacteria identiﬁed, by culturing, in each sample. The
analysis was performed for fecal and hypopharyngeal samples separately and at all taxonomic levels from Phylum to Species (x-axis) and the color of each
box denotes the timepoint
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identiﬁed by culturing, amplicon sequencing identiﬁed the same
bacteria from the same sample. Likewise, counting each time one
of the 106 bacteria was identiﬁed in a sample, culturing had only
identiﬁed the same bacterium from the same sample 23.86% of
the times (Supplementary Table 6).
Some bacteria were only detected by culturing and not by
amplicon sequencing. For example, culturing identiﬁed Haemo-
philus inﬂuenzae in 110 samples where it was not detected by
sequencing, Streptococcus pluranimalium (n= 110), Enterococcus
casseliﬂavus (n= 84), Staphylococcus haemolyticus (n= 53), and
Enterococcus faecium (n= 43), none of which were identiﬁed by
sequencing (Supplementary Table 7). NGS identiﬁed many of the
taxa more frequently than culturing, Haemophilus haemolyticus
was, except for one culture positive sample, only detected by
sequencing (n= 1,231). Similarly, e.g., Streptococcus salivarius
and S. vestibularis (sequencing: n= 1,997, culturing: n= 16, both:
n= 133), Streptococcus mitis (sequencing: n= 1,781, culturing:
n= 16, both: n= 359).
The relative abundance in the sequenced results within each
sample affected the likelihood of detecting the bacteria by
culturing. When classifying bacteria, in each sample, by their
relative abundances (by sequencing) higher than 10 % as
dominant, from 1 to 10% as major, and lower than 1% as minor,
we found a positive correlation (chi-square test, p-value < 0.05) to
the probability of identifying it by culturing. Of the dominant
bacteria, 49.76% were also identiﬁed by culturing, while 17.88% of
major and 7.66% of minor bacteria were identiﬁed (Fig. 2,
Supplementary Table 6). This correlation were very clear when
looking at the probability of identifying speciﬁc bacteria such as,
Staphylococcus GroupA (92.69, 67.80, or 42.88% when dominant,
major or minor, respectively), Escherichia/Shigella group (79.23,
31.16, or 6.79%, respectively) or Enterobacteriaceae group A
(69.52, 33.33, or 10.44%, respectively) (Supplementary Table 7).
Amplicon sequencing resolution. Amplicon sequencing was
more sensitive than culturing, identifying more bacteria per
sample than culturing (mean 26.4 vs 2.33 bacteria per sample,
Table 2), despite including only sequences with 100% matches to
the reference database, but did not have sufﬁcient resolution. In a
clinical setting, the difference between the species S. aureus and S.
epidermidis is very relevant, but the V4 region of the 16S rRNA
gene from the two species are 100% identical. For Enterobacter-
iaceae, the problem is more pronounced, as many genera cannot
be separated based on the sequence of their V4 region of the 16S
rRNA gene. An in silico comparison of the resolution, if both
variable region V3 and V4 had been sequenced, found that for
species from S. aureus group, three would still have identical
sequences (S. epidermidis, S. capatis, and S. caprae), but notably,
S. aureus would not be identical to any other species (Fig. 3a). For
Enterobacteriaceae, all species could be further separated if vari-
able region 3 were included (Fig. 3b).
Table 2 Richness of samples by closed-reference OTU picking and culturing. Shown for all samples and split by sample type and
sample time-point. The mean, standard deviation (SD), minimum number of species (Min), and the maximum number of species
(Max) identiﬁed using both methods are listed
Type Time Mean Min Max SD
Culture Fecal One Week 2.30 0 5 1.00
One Month 2.19 0 6 1.03
One Year 2.22 0 7 1.08
Hypopharyngeal One Week 2.41 0 7 1.20
One Month 2.42 0 6 1.23
Three Months 2.42 0 8 1.26
Amplicon sequencing Fecal One Week 22.55 7 82 10.51
One Month 21.94 3 100 9.27
One Year 52.22 8 119 18.00
Hypopharyngeal One Week 16.12 2 137 9.02
One Month 20.12 3 140 10.77
Three Months 25.18 1 99 11.12
0%
10%
20%
30%
40%
50%
60%
All Fecal Hypopharyngeal
Sequenced confirmed by culturing
Dominant Major Minor All
Fig. 2 Barplot showing the percentage of bacteria identiﬁed by amplicon sequencing that were also identiﬁed by TCM in the same sample. The three groups
of bars (x-axis) show the result for the different sample types (all together or fecal and hypopharyngeal samples separately). Blue bars show the result for
dominant bacteria (abundance >10%), orange show major bacteria (1–10%), and gray show minor bacteria (<1%), while the yellow line indicates the
overall percentage for each sample type
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Additionally, as shown earlier H. inﬂuenzae was found in
110 samples using TCM, but never using amplicon sequencing,
while the closely related species H. haemolyticus was only found
in a single sample using TCM, but in 1,231 samples by amplicon
sequencing. The sequences for the two species are >99% identical
(251/253 bp) and of the 110 samples where TCM had identiﬁed
H. inﬂuenzae amplicon sequencing found H. haemolyticus in 92,
and in none of these were H. haemolyticus found by TCM (110/
92/0). For the other species that were often not identiﬁed by
amplicon sequencing, we were not able to ﬁnd a similarly clear
pattern: The closest related species to S. pluranimalum (S.
thoraltensis) were not found by sequencing either. E. faecalis/
durans/hirae were the closest sequence to both E. casseliﬂavus and
E. faecium, but when comparing the times they were found by
TCM to when E. faecalis/durans/hirae were identiﬁed by
amplicon sequencing and by TCM as well, the pattern were not
as clear (84/27/7 for E. casseliﬂavus and 43/24/5 for E. faecium).
For S. haemolyticus closest sequence were the Staphylococcus
GroupA which were abundant by itself (53/41/36).
Discussion
We performed a comparative evaluation for a large set of samples
by means of culture-dependent and molecular diagnostics
methods. Using a Naive Bayes classiﬁer for taxonomical assign-
ment of the sequencing data we were able to assign taxonomy to
all ASVs, but only 4% of all sequencing reads were identiﬁed at
species level. Some of the taxonomical unresolved ASV are likely
to represent species that are not represented in RDP, while a large
part will be from very well described bacterial genera or families
where the V4 region of 16S rRNA gene does not provide sufﬁ-
cient resolution to differentiate multiple species. In addition to a
decreased proportion of sequencing reads matching taxa cultured
from each sample with each taxonomic level, we found a decrease
over time and a lower proportion in fecal samples compared to
hypopharyngeal samples. We speculate, that the two main rea-
sons for this lower proportion in fecal compared to hypophar-
yngeal samples may in part be explained by the fact that no strict
anaerobe bacteria were identiﬁed to species level using TCMs
from the airways, and that the complex bacterial community of
the gut contains species with very narrow growth requirements
and slow growth rates, which are identiﬁed by amplicon
sequencing but cannot be cultured using TCMs.
We used a naive Bayes classiﬁer for our initial taxonomical
classiﬁcation of sequences, which ensures that all reads get the
best possible taxonomical classiﬁcation at the expense of some
resolution. For many forms of research, this is important, as it
enables classiﬁcation of unknown bacteria without skewing the
data towards well described bacterial taxa. In most clinical setups,
the presence of a speciﬁc bacteria would be more important than
an unbiased overview with unknown bacteria. Therefore, we
created a non-redundant database containing strain type
sequences for all bacteria that were cultured from these samples,
using TCMs, and performed closed reference taxonomical clas-
siﬁcation against it. While still being limited by the lack of cul-
tured anaerobe bacteria and bacterial species not having a
sequenced type strain, this approach closely resembles a likely
clinical setup. With this approach, we matched 76.63% of
sequences from hypopharyngeal samples to species cultured in
the same sample and 26.50% from fecal samples (Supplementary
Fig. 2). While this is an improvement compared to the initial
analysis we still see that the upper respiratory tract harbors fewer
uncultured bacteria in comparison to the gut where they repre-
sent a large percentage of the microbiota14.
We found large differences in sensitivity of the two methods,
identifying 7–20 times more unique species with NGS than with
TCMs. Especially from fecal samples TCMs identify very few
unique species, even slightly less than in hypopharyngeal samples
and only NGS showed the expected increase in diversity that have
been shown previous studies15,16. While NGS would be expected
to have higher sensitivity, this comparison includes the data from
closed reference tax assignment, which means that all bacteria
identiﬁed by amplicon sequencing had been identiﬁed in at least
once by TCMs, this cannot be attributed to an inability to culture
any speciﬁc bacteria. To investigate the possibility of this being
related to low abundant bacteria not being identiﬁed using TCMs,
we grouped the bacteria sequenced in each sample as dominant
(>10%), major (1–10%) or minor (<1%). Our comparison clearly
shows that dominant bacteria, in general, were more likely to be
identiﬁed by TCMs, and when comparing within individual
species, this provided even stronger support for TCMs being
biased by the relative abundance of each bacteria, which may be a
good thing in a clinical setting, where you have no intention on
initializing treatment on a bacteria that is not infecting but only
colonizes. The surprisingly low number of fecal bacteria identiﬁed
by TCMs may be due to more difﬁculty culturing at lower relative
abundance. This was especially clear in the 1 year fecal samples,
where <9% of the microbial community belonged to bacteria
which were cultured (Supplementary Fig. 2). TCMs failed to
detect ~50% of the dominant bacteria identiﬁed by amplicon
sequencing, while >80% of the major bacteria were not detected
by TCMs.
Sequencing just one variable region of 16S rRNA gene was not
sufﬁcient to consistently separate the bacterial species, identiﬁed
by culturing, to species level. Our in silico analysis, extending the
ampliﬁed region to include both variable region V3 and V4,
showed an increased resolution when comparing clusters of
species with 100% sequence identity in variable region V4.
Additionally, our results show that amplicon sequencing had
some problems with correct separation of sequences that differ in
0.001
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Staphylococcus_aureus
Staphylococcus_capitis
Staphylococcus_pasteuri
Staphylococcus_warneri
Staphylococcus_epidermidis
Staphylococcus_lugdunensis
Staphylococcus_caprae
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Leclercia_adecarboxylata
Enterobacter_aerogenes
Enterobacter_cloacae
Enterobacter_asburiae
Kluyvera_cryocrescens
Kluyvera_intermedia
Lelliottia_amnigena
Klebsiella_oxytoca
Klebsiella_pneumoniae
a b
Fig. 3 Phylogenetic trees showing how groups of bacteria with identical V4 sequences separate when using the V3–V4 regions. a Staphylococcus aureus
group and b Enterobacteriaceae group A
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as little as 1–2 bp out of 253 bp. An important step in the process
is to create an error model that can infer if a single nucleotide
difference is a sequencing error or an actual sequence variant, and
it is possible that with the high sequence similarity the error
model wrongly classiﬁes the differences as a sequencing error and
then changes the sequences to match the closest matching
sequence.
With a well-curated reference database, for clinical relevant
bacteria, a 16S rRNA gene amplicon sequencing workﬂow could
be implemented to provide a plug and play output showing an
overall picture of the microbial community and accurately
identify relevant bacterial species. This combined with optimized
oligonucleotide arrays for detecting various genes, including those
encoding for resistance and toxins, as well as distinguishing
speciﬁc species could very well be a game changer for diag-
nosticians. Our ﬁndings show that with the development of a
standardized and automated pipeline sequencing will be ready to
replace TCMs. However, even if TCM were to be replaced for
clinical testing, there is still a need for further reﬁning culture
techniques for research involving bacterial behavior and
interactions.
Methods
Ethics. The study follows the principles of the Declaration of Helsinki and was
approved by the Ethics Committee for Copenhagen (The Danish National Com-
mittee on Health Research Ethics) (H-B- 2008–093) and the Danish Data Pro-
tection Agency (2008–41–2599). Written informed consent was obtained from all
participants. The study is reported in accordance with the STROBE guidelines17.
Written consent for publication has been obtained from the parents or legal
guardians of all participants.
Study population. The novel Copenhagen Prospective Study on Asthma in
Childhood 2010 (COPSAC2010) is an ongoing Danish cohort study of 743 unse-
lected pregnant women and their children followed prospectively from pregnancy
week 24 in a protocol largely similar to the ﬁrst COPSAC birth cohort (COP-
SAC2000)13,18,19. Recruitment lasted during 2009–10. Exclusion criteria were
chronic cardiac, endocrinological, nephrological or lung disease other than asthma.
Sample collection. Hypopharyngeal aspirates were collected at 1 week (537 sam-
ples), 1 month (626 samples), and 3 months (627 samples) after birth. Fecal
samples were collected at 1 week (542 samples), 1 month (597 samples), and
12 months (609 samples)13. All 3,538 samples were transported to Statens Serum
Institut (Copenhagen, Denmark) where they were cultured and stored within 24 h
of sampling.
Culturing. Bacterial samples were cultured with standard methods on non-selective
and selective media (SSI Diagnostica, Hillerød, Denmark). One set of blood agar
plates and chocolate agar plates (both supplemented with 5% horse blood) were
incubated aerobically at 37 °C for 18–20 h. Another set of blood agar and chocolate
agar plates were incubated under microaerophilic conditions (5% CO2, 3% H2, 5%
O2 and 87% N2) at 37 °C for 48 h. Fecal samples were cultured on an anaerobic
plate, under anaerobic conditions at 37 °C for 72 h. Subsequently, based on the
growth on selective media, characteristics of colonies, and cellular morphology, all
unique bacterial colonies were isolated. All bacterial isolates were identiﬁed bio-
chemically by the automated identiﬁcation system VITEK-2 (BioMérieux, France).
Bacteria cultured anaerobically were not identiﬁed further. All isolates were pre-
served at −80 °C. No quantiﬁcation was performed20.
Amplicon sequencing. DNA extraction and 16S rRNA gene amplicon sequencing
was done in the same way as published in our earlier studies21. Primers were
removed from the MiSeq generated FASTQ ﬁles by cutadapt22. Further, reads were
analyzed by QIIME223 pipeline using DADA224 to create sequencing error proﬁles,
trim (ﬁrst 8 bp of each read), truncate (forward reads to 180 bp, reverse reads to
160 bp), assemble read pairs, remove chimeras, infer the amplicon sequence var-
iants (ASVs) present and assign taxonomy using a pre-trained Naive Bayes clas-
siﬁer [Silva Ref NR 99 (release 132)]25. Based on the rarefaction curves for observed
richness and Shannon diversity index (Supplementary Fig. 3), samples with <2,000
reads were excluded from the analysis, as well as 3 samples with an unusually high
richness, which were suspected to be technical artifacts. In total 3,538 samples
(1,748 fecal and 1,790 hypopharyngeal) were included for the comparisons. To
avoid the bias due to sampling depth, the OTU table was multiple rareﬁed to 1,806
high-quality sequences per sample (90% of the minimum sample reads) using the
in-house function.
Closed reference OTU picking. Based on the cultured species, a reference data-
base was created from the matching type strains in the RDP database for V4 region
only26. ASVs were matched at 100% using pick_closed_reference_otus.py script in
QIIME among 3,538 samples.
The abundances of the bacteria were calculated as the percent of all reads,
including those, which did not match to the reference database. Based on their
abundances the bacteria were classiﬁed as dominant bacteria (abundance >10%),
major (1–10%), or minor (<1%).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The sequences were submitted in NCBI Sequence Read Archive (SRA) under the
Bioproject ID PRJNA543007. The contingency table showing which bacteria were
isolated from each sample has been attached as Supplementary data ﬁle. All other data is
available from the corresponding author.
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